- Home
- BFIN vs OBIO Comparison
BFIN vs OBIO Comparison
Compare BFIN & OBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BFIN
- OBIO
- Stock Information
- Founded
- BFIN 1924
- OBIO 2017
- Country
- BFIN United States
- OBIO United States
- Employees
- BFIN N/A
- OBIO N/A
- Industry
- BFIN Savings Institutions
- OBIO Medicinal Chemicals and Botanical Products
- Sector
- BFIN Finance
- OBIO Health Care
- Exchange
- BFIN Nasdaq
- OBIO Nasdaq
- Market Cap
- BFIN 145.5M
- OBIO 118.8M
- IPO Year
- BFIN N/A
- OBIO N/A
- Fundamental
- Price
- BFIN $11.89
- OBIO $3.01
- Analyst Decision
- BFIN
- OBIO Strong Buy
- Analyst Count
- BFIN 0
- OBIO 5
- Target Price
- BFIN N/A
- OBIO $14.20
- AVG Volume (30 Days)
- BFIN 93.0K
- OBIO 369.5K
- Earning Date
- BFIN 07-30-2025
- OBIO 08-11-2025
- Dividend Yield
- BFIN 3.38%
- OBIO N/A
- EPS Growth
- BFIN N/A
- OBIO N/A
- EPS
- BFIN 0.36
- OBIO N/A
- Revenue
- BFIN $48,547,000.00
- OBIO $2,886,000.00
- Revenue This Year
- BFIN N/A
- OBIO $20.47
- Revenue Next Year
- BFIN $6.40
- OBIO $11.45
- P/E Ratio
- BFIN $33.20
- OBIO N/A
- Revenue Growth
- BFIN N/A
- OBIO 30.23
- 52 Week Low
- BFIN $10.15
- OBIO $2.37
- 52 Week High
- BFIN $13.97
- OBIO $8.87
- Technical
- Relative Strength Index (RSI)
- BFIN 50.48
- OBIO 51.30
- Support Level
- BFIN $11.61
- OBIO $2.78
- Resistance Level
- BFIN $11.90
- OBIO $2.94
- Average True Range (ATR)
- BFIN 0.28
- OBIO 0.21
- MACD
- BFIN 0.05
- OBIO -0.00
- Stochastic Oscillator
- BFIN 66.67
- OBIO 60.87
About BFIN BankFinancial Corporation
BankFinancial Corp is a full-service, national bank providing banking, financial planning and fiduciary services to individuals, families and businesses in the Chicago metropolitan area and on a regional or national basis for commercial finance, healthcare finance, equipment finance, commercial real estate finance and treasury management business customers. The Bank offers its customers a broad range of loan, deposit, trust and other financial products and services through approximately 18 full-service banking offices located in Cook, DuPage, Lake and Will Counties, Illinois and through its Internet Branch.
About OBIO Orchestra BioMed Holdings Inc.
Orchestra BioMed Holdings Inc is a biomedical innovation company accelerating high-impact technologies to patients through risk-reward sharing partnerships. Its partnership-enabled business model focuses on forging strategic collaborations with medical device companies to drive the commercialization of the products it develops. The company's flagship product candidates include BackBeat Cardiac Neuromodulation Therapy (CNT) for the treatment of hypertension and Virtue Sirolimus AngioInfusionBalloon (SAB) for the treatment of atherosclerotic artery disease.